Stay updated on Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page history now includes a new Revision: v3.6.6 entry, replacing the previous Revision: v3.6.5. This reflects a small update to the page's revision metadata and does not alter the visible trial information.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe Record History page now shows revision v3.6.5, replacing v3.6.4. This signals a small platform update to the page rendering rather than any change to trial data.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now shows Revision: v3.6.4, reflecting a minor system update to the record history interface. No study content or historical entries are modified.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision: v3.6.3 is now shown, replacing Revision: v3.6.2 in the page footer. This indicates a routine update to the history-view interface of the study record.SummaryDifference0.0%

- Check75 days agoChange DetectedThe Revision tag on the History page was updated to v3.6.2, replacing the previous v3.6.0. This indicates a minor update to the page’s versioning rather than substantive changes to trial content.SummaryDifference0.0%

- Check82 days agoChange DetectedA new history entry dated 2026-06-17 adds Contacts/Locations and Study Status sections to the record. This also includes a related 2026-06-16 entry and a numeric value 100, indicating updates to the study history data.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.